Type 2 Diabetes and the Older Adult

Please read the following information and select the appropriate link at the bottom of the page to continue.

Target Audience: Pharmacists, nurses, and dietitians who are involved with patient education and counseling

Goal: To increase awareness about the diagnosis and treatment of type 2 diabetes in older patients

Educational Objectives: Upon completion of this activity participants should be able to:

• Discuss effect of aging on development of type 2 diabetes
• List five special considerations for diabetes management of the older adult
• Describe three pharmacological therapies used in older adults with diabetes
• List four assessments needed when using insulin in the older adult

Pharmacists: The American Association of Diabetes Educators and Novo Nordisk Pharmaceuticals, Inc. are accredited by the American Council on Pharmaceutical Education (ACPE) as providers of continuing pharmaceutical education. This program provides for 1.25 contact hours (0.125 CEUs). ACPE Universal Program Number 069-360-02-872-H04

Registered Nurses: This program for 1.5 contact hours has been approved by the American Association of Diabetes Educators which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center's Commission of Accreditation. Approval of this continuing education activity does not imply endorsement by AADE. Approval number 0203-011

Dietitians: American Association of Diabetes Educators (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from June 1, 2003 to May 31, 2006. Registered dietitians (RD) and dietetic technicians, registered (DTR) will receive 1.0 Continuing Professional Education Units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Initial Release Date: 12/04/02
Planned Expiration Date: 12/04/04

To receive a statement of credit, you must:

• Successfully complete the post-test (70% or better).
• Complete the program evaluation.

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form. The statement of credit specific to your discipline will appear on your screen and you will be given the option to print it for your files. No additional statement of credit will be issued.

Activity Presenter:

Jerry Meece, R.Ph., F.A.C.A., C.D.E.
Pharmacist and Certified Diabetes Educator
Owner and Director of Clinical Services
Plaza Pharmacy and Wellness Center
Gainesville, Texas

The following program is a presentation by Jerry Meece.  Mr. Meece is a pharmacist and Certified Diabetes Educator who is owner and Director of Clinical Services of Plaza Pharmacy and Wellness Center in Gainesville, Texas. Mr. Meece has written many articles on diabetes care and insulin use in the patient with diabetes. He has also spoken across the country on the subject of diabetes and disease state management in the pharmacy setting. Mr. Meece currently serves on the Board of Directors for the American Association of Diabetes Educators and is also chairman of the Public Affairs Committee for that organization.

Fee: There is no fee to receive credits for this program.

Commercial Supporter: This program has been supported through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

Trademarks:

Diabinese, Glucotrol, and Glucotrol XL are registered trademarks of Pfizer Inc.
Micronase, Glynase, Tolinase, and Orinase are registered trademarks of Pharmacia-Upjohn Corporation.
Glyset is a trademark of Bayer Corporation, licensed to Pharmacia.
DiaBeta and Amaryl are registered trademarks of Hoechst Marion Roussel, Division of Aventis Pharmaceuticals.
Actos is a registered trademark of Takeda Pharmaceuticals America, Inc.
Avandia is a registered trademark of GlaxoSmithKline.
Avandamet is a trademark of GlaxoSmithKline.
Precose is a registered trademark of Bayer Corporation.
Glucophage and Glucovance are registered trademarks of Merck Santé S.A.S. licensed to Bristol-Myers Squibb Company.
Metaglip is a trademark of Merck Sante S.A.S. licensed to Bristol-Myers Squibb Company.
Starlix is a registered trademark of Novartis Pharmaceuticals Corporation.
Prandin, Novolin, NovoLog, NovoFine, NovoPen, Lente, and Ultralente are registered trademarks of Novo Nordisk A/S.
Humalog and Humulin are registered trademarks of Eli Lilly and Company.
Lantus is a registered trademark of Aventis Pharmaceuticals.

Disclosure Declaration: It is the policy of Novo Nordisk Pharmaceuticals, Inc. and the American Association of Diabetes Educators to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in the activity or with the supporter of this continuing education activity. The information is for participant information; it is not assumed that these relationships will have a negative impact on the content of the activity.

Jerry Meece has disclosed that he is a consultant for Eli Lilly and Company and LifeScan Inc., a Johnson and Johnson company. He is also on the speaker's bureau for Eli Lilly and Company, LifeScan, and Novo Nordisk Pharmaceuticals, Inc.

Disclaimers:

• Approval of credit for this continuing education program does not imply endorsement by AADE of any product or manufacturer identified.
• Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
• This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA).
• Novo Nordisk Pharmaceuticals, Inc., the American Association of Diabetes Educators, and the activity's faculty do not endorse the use of any product in a manner that is not approved by the FDA.

  The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
  

Click the appropriate profession to continue to the activity:

Pharmacists click here

Nurses click here

Dietitians click here

For our Terms of Use and Privacy Policy, please review our Legal Agreement.
Copyright© 2004 CECity® All rights reserved.